ReviewAnnals of intensive care2026
How to perform fluid de-escalation in critical care.
Review in Annals of intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deconstructing Risk: A Machine Learning-Guided Logistic Regression Model for Predicting Early Mucosal Edema Following Prophylactic Ileostomy in Elderly Rectal Cancer Patients.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fluid management is a core aspect of critical care, guiding decisions around the type, timing, and amount of fluid therapy. The administration of intravenous fluids aims to restore and maintain tissue perfusion, replace overt losses, and serve as a carrier for drug delivery. While fluid administration is often emphasised during the resuscitation phase, growing evidence highlights the risks associated with sustained positive fluid balance, including tissue oedema, organ dysfunction, and increased mortality. A clear understanding of the pathophysiological mechanisms underlying fluid homeostasis can support decision-making during fluid de-escalation. Recognising the role of the lymphatic system in interstitial fluid clearance, and its potential impairment during critical illness, may help guide appropriate timing and realistic expectations for fluid removal. Fluid de-escalation includes limiting fluids to daily physiological needs, and when excess fluid persists, active fluid removal using pharmacological or mechanical interventions may be required. Evidence supporting adjunctive measures, such as albumin, hypertonic saline, or compression techniques, remains limited. There is increasing interest in understanding whether treatment effects differ across patient phenotypes, and studies in patients with lung injury suggest this may also apply to fluid management strategies. In one study, hyperinflammatory patients appeared to benefit from a conservative fluid approach, while hypoinflammatory patients had worse outcomes, despite no overall difference in mortality between the strategies. These findings highlight the potential value of phenotype-guided fluid strategies. Although fluid de-escalation is clinically important, evidence on the optimal timing, volume, and duration of fluid removal remains limited. While individualized ICU care often incorporates real-time hemodynamic variables, current strategies rely heavily on clinical judgment in the absence of standardized criteria. It also remains unclear whether a degree of permissive hemodynamic instability might be acceptable for preventing or reversing fluid overload. Ultimately, weaning from fluid support should be seen as a continuous, individualized process. Ward round discussions should explicitly name fluid overload as a working diagnosis and recognise persistent fluid accumulation or difficulty in removal as a barrier to recovery, comparable to difficult weaning from mechanical ventilation or ICU-acquired weakness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.